Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

GnRH treatment can reduce breast cancer cell invasion.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

A new method accurately measures cell changes in breast cancer.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Angelica Sinensis and Chinese Arborvitae have various medicinal benefits, including anti-inflammatory and anti-cancer effects.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.